Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.780
+0.040 (2.30%)
At close: Nov 1, 2024, 4:00 PM
1.740
-0.040 (-2.25%)
After-hours: Nov 1, 2024, 6:59 PM EDT

Heron Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
136.36127.04107.6786.3588.64145.97
Upgrade
Revenue Growth (YoY)
15.60%17.99%24.70%-2.59%-39.28%88.41%
Upgrade
Cost of Revenue
95.78117158.18175.64209.52229
Upgrade
Gross Profit
40.5910.04-50.51-89.3-120.88-83.03
Upgrade
Selling, General & Admin
79.21103.06118.75127.13101.68127.66
Upgrade
Operating Expenses
69.38103.06118.75127.13101.68127.66
Upgrade
Operating Income
-28.79-93.02-169.26-216.43-222.56-210.69
Upgrade
Interest Expense
-5.57-3.87-2.47-2.41-1.9-1.47
Upgrade
Interest & Investment Income
3.363.361.640.433.637.26
Upgrade
Other Non Operating Income (Expenses)
3.281.18-6.32-0.4-0.26
Upgrade
EBT Excluding Unusual Items
-27.72-92.34-176.42-218.81-220.83-204.65
Upgrade
Merger & Restructuring Charges
-4.2-4.2-5.4-1.4-5.6-
Upgrade
Gain (Loss) on Sale of Investments
-0-0---0.01
Upgrade
Asset Writedown
-0.31-0.62-0.21-0.48-0.85-0.11
Upgrade
Other Unusual Items
-13.4-13.4----
Upgrade
Pretax Income
-48.13-110.56-182.02-220.68-227.28-204.75
Upgrade
Net Income
-48.13-110.56-182.02-220.68-227.28-204.75
Upgrade
Net Income to Common
-48.13-110.56-182.02-220.68-227.28-204.75
Upgrade
Shares Outstanding (Basic)
154138109989182
Upgrade
Shares Outstanding (Diluted)
154138109989182
Upgrade
Shares Change (YoY)
31.37%26.87%10.57%8.48%11.00%11.73%
Upgrade
EPS (Basic)
-0.31-0.80-1.67-2.24-2.50-2.50
Upgrade
EPS (Diluted)
-0.31-0.80-1.67-2.24-2.50-2.50
Upgrade
Free Cash Flow
-22.52-60.33-148.74-206.38-191.63-131.73
Upgrade
Free Cash Flow Per Share
-0.15-0.44-1.37-2.10-2.11-1.61
Upgrade
Gross Margin
29.76%7.90%-46.91%-103.42%-136.38%-56.88%
Upgrade
Operating Margin
-21.11%-73.21%-157.20%-250.65%-251.09%-144.34%
Upgrade
Profit Margin
-35.29%-87.02%-169.05%-255.58%-256.41%-140.27%
Upgrade
Free Cash Flow Margin
-16.52%-47.49%-138.14%-239.01%-216.20%-90.25%
Upgrade
EBITDA
-26.02-90.12-166.37-213.41-219.72-208.65
Upgrade
EBITDA Margin
-19.08%-70.93%-154.51%-247.15%-247.88%-142.94%
Upgrade
D&A For EBITDA
2.772.92.893.022.852.04
Upgrade
EBIT
-28.79-93.02-169.26-216.43-222.56-210.69
Upgrade
EBIT Margin
-21.11%-73.21%-157.20%-250.65%-251.09%-144.34%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.